You are viewing: France Empty Capsules Market analysis
Part of: Empty Capsules Market (Global)

The France Empty Capsules Market was valued at $77.5 Million in 2025 and projected to reach to $98.8 Million by 2030, representing a compound annual growth rate of 5.0%. France's empty capsules market is poised for steady growth through 2030, driven by the country's strong pharmaceutical manufacturing base and expanding nutraceutical sector.

France Empty Capsules Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Empty Capsules Market Trends and Insights

  • France represents a significant segment within the European pharmaceutical and nutraceutical sectors, where empty capsules serve as critical delivery mechanisms for both prescription and over-the-counter formulations.
  • The market in France is driven by robust pharmaceutical manufacturing, increasing demand for personalized medicine, and growing consumer preference for capsule-based supplements. The growth trajectory in France reflects broader European trends toward advanced drug delivery systems and quality manufacturing standards.
  • France's established pharmaceutical infrastructure and regulatory framework support consistent demand for high-quality empty capsules across gelatin and plant-based variants.
  • Between 2025 and 2030, France is expected to benefit from rising healthcare expenditure, expansion of contract manufacturing organizations, and increased adoption of capsule-based nutraceuticals among health-conscious consumers..

Key Market Statistics

  • CAGR (2025-2030) 5.0% CAGR
  • Market Size, 2025 ~USD 77.5 Million
  • Forecast, 2030 ~USD 98.8 Million
  • Country France

France Empty Capsules Market Overview

Market Valuation :

France's empty capsules market is valued at USD 77.5 million in 2025, with projected growth to USD 98.8 million by 2030, representing a steady 5.0% CAGR aligned with European pharmaceutical standards.

Pharmaceutical & Nutraceutical Integration :

Empty capsules are integral to France's robust pharmaceutical and nutraceutical sectors, serving as primary delivery mechanisms for both prescription medications and over-the-counter wellness products across diverse therapeutic categories.

European Market Position :

France maintains a significant position within the European empty capsules landscape, benefiting from stringent regulatory frameworks, advanced manufacturing capabilities, and high consumer demand for quality pharmaceutical formulations.

Growth Trajectory :

With a 5.0% CAGR through 2030, France's market demonstrates consistent expansion driven by increasing pharmaceutical production, rising nutraceutical consumption, and growing preference for capsule-based delivery systems among French consumers.

France Empty Capsules Market Dynamics

  • The French market benefits from stringent EU regulatory compliance, which ensures high-quality capsule production standards and supports premium positioning.
  • Increasing consumer preference for convenient dosage forms and the rise of personalized medicine are expected to sustain demand across both prescription and OTC segments. The market outlook remains positive as French pharmaceutical companies invest in advanced capsule technologies and sustainable manufacturing practices.
  • Growing health consciousness among French consumers, coupled with the expansion of e-commerce channels for nutraceuticals, will further accelerate market penetration.
  • Strategic partnerships between local manufacturers and international suppliers are anticipated to enhance product innovation and market accessibility throughout the forecast period..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • France's empty capsules market is valued at USD 77.5 million in 2025 and will reach USD 98.8 million by 2030.
    • France is experiencing a 5.0% CAGR, reflecting steady demand from pharmaceutical and nutraceutical manufacturers.
    • France's strong regulatory environment and pharmaceutical infrastructure support premium capsule product demand.
    • France's market growth is driven by personalized medicine trends and increasing consumer adoption of capsule-based supplements.

    Empty Capsules Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment SUSTAINED-RELEASE CAPSULES (Functionality)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.6% from 2025 to 2030
    Largest Segment IMMEDIATE-RELEASE CAPSULES (Functionality)
    Market Size Base Year (Billions) ~USD 3.19 (2025)
    Revenue Forecast (Billions) ~USD 4.19 (2030)
    Segments Covered Type, Raw Material, Functionality, Size, Therapeutic Application, End User

    France Empty Capsules Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Gelatin Capsules
    • Non-Gelatin Capsules

    By Raw Material

    • Bonemeal Gelatin
    • Bovine-Derived Gelatin
    • Hydroxypropyl Methylcellulose (Hpmc)
    • Other Gelatin Sources
    • Porcine Gelatin
    • Pullulan & Starch

    By Functionality

    • Delayed-Release Capsules
    • Immediate-Release Capsules
    • Sustained-Release Capsules

    By Size

    • Size 0
    • Size 00
    • Size 000
    • Size 1
    • Size 2
    • Size 3
    • Size 4
    • Size 5

    By Therapeutic Application

    • Antacid & Antiflatulent Preparations
    • Anti-Inflammatory Drugs
    • Antianemic Preparations
    • Antibiotic & Antibacterial Drugs
    • Cardiovascular Therapy Drugs
    • Cough & Cold Drugs
    • Dietary Supplements
    • Other Therapeutic Applications

    By End User

    • Cosmetic Industry
    • Nutraceutical Industry
    • Pharmaceutical Industry
    • Research Laboratories

    FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    COSMETIC INDUSTRY9.59.710.110.611.111.712.3135.2
    NUTRACEUTICAL INDUSTRY39.640.442.344.54749.752.655.95.7
    PHARMACEUTICAL INDUSTRY505153.35659.162.466705.6
    RESEARCH LABORATORIES5.15.25.45.65.96.26.56.84.9
    TOTAL104.2106.3111.2116.8123.1129.9137.5145.85.6

    Target Audience

    • Pharmaceutical Manufacturers : French and European pharmaceutical companies require detailed market data to optimize capsule sourcing strategies, forecast demand for prescription formulations, and plan production capacity investments aligned with market growth.
    • Nutraceutical & Supplement Producers : Nutraceutical companies operating in France need market insights to understand capsule demand trends, consumer preferences for delivery formats, and competitive positioning within the growing wellness and dietary supplement segment.
    • Capsule Manufacturers & Suppliers : Empty capsule producers and raw material suppliers require France-specific market data to identify growth opportunities, assess competitive intensity, and develop targeted sales strategies for pharmaceutical and nutraceutical customers.
    • Healthcare Investors & Private Equity : Investment firms evaluating opportunities in the French pharmaceutical and nutraceutical sectors need comprehensive market analysis to assess growth potential, identify acquisition targets, and evaluate portfolio company performance.
    • Regulatory & Compliance Consultants : Consultants advising companies on market entry and regulatory compliance in France require detailed market intelligence to provide informed guidance on manufacturing standards, quality requirements, and competitive positioning strategies.

    Key Companies in the France Empty Capsules Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing, packaging, lifecycle management),Pharmaceutical development services (formulation, clinical trial supply),Drug substance services (API and biologics substance),
    ALLERGAN PLCIrelandPrivate CompanyMedical aesthetics and dermatology,Eye care,Neuroscience and CNS,
    HELM AGGermanyPrivate CompanyBasic Chemicals, Acids and Lyes,Plastics and Polyurethanes,Crop Protection and Fertilizers,
    SUNIL HEALTHCARE LIMITEDIndiaPublic CompanyStandard empty hard gelatin capsules (incl. BSE/TSE free, pearl, natural color),Functional and specialty capsules (liquid-fill, preservative-free, stick-free, flavored, SLS-free, non-AZO),HPMC/vegetable capsules,
    NATURAL CAPSULES LIMITEDIndiaPublic CompanyStandard hard gelatin capsule shells,Vegetarian and cellulose-based capsule shells,Enteric, fast-release, and functional capsules,
    ANHUI HUANGSHAN CAPSULE CO., LTD.ChinaPublic CompanyVacant gelatin capsules (standard),Enteric-coated / entersoluble gelatin capsules,Vegetable capsules (HPMC, pullulan, vegetable entersoluble),

    PATHEON INC

    Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and contract manufacturing sector.

    ALLERGAN PLC

    Allergan PLC is an Ireland-incorporated private company founded in 1983 with 17,400 employees, operating in the pharmaceutical and specialty healthcare industry.

    HELM AG

    Helm AG is a Germany-based private company founded in 1900 with 1,430 employees, operating in the pharmaceutical and chemical distribution industry.

    SUNIL HEALTHCARE LIMITED

    Sunil Healthcare Limited is an India-based public company founded in 1973 with 161 employees operating in the pharmaceutical sector.

    NATURAL CAPSULES LIMITED

    Natural Capsules Limited is an India-based public company founded in 1993 with 615 employees operating in the pharmaceutical capsule manufacturing industry.

    ANHUI HUANGSHAN CAPSULE CO., LTD.

    Anhui Huangshan Capsule Co., Ltd. is a China-based public company founded in 1989 with 639 employees operating in the pharmaceutical capsule manufacturing industry.

    Reasons to Buy this Report

    • Localized Market Intelligence : Gain France-specific insights into market size, growth rates, and competitive dynamics that are essential for tailoring product strategies and market entry approaches within the French pharmaceutical and nutraceutical sectors.
    • Regulatory & Compliance Guidance : Understand France's stringent EU regulatory requirements for empty capsule manufacturing, quality standards, and compliance frameworks that directly impact production planning and market positioning decisions.
    • Competitive Landscape Analysis : Identify key French and European competitors, market consolidation trends, and differentiation opportunities specific to the French market to inform strategic positioning and partnership development.
    • Growth Opportunity Identification : Leverage France-specific CAGR projections (5.0% through 2030) to identify high-growth segments within pharmaceuticals and nutraceuticals, enabling targeted investment and resource allocation decisions.
    • Strategic Market Entry Planning : Develop data-driven market entry strategies with France-specific demand forecasts, distribution channel insights, and consumer preference analysis to maximize ROI and accelerate market penetration.

    Frequently asked questions

    What is the current size of the empty capsules market in France?

    The empty capsules market in France is valued at USD 77.5 million in 2025.

    What is the projected market size for empty capsules in France by 2030?

    France's empty capsules market is projected to reach USD 98.8 million by 2030.

    What is the growth rate of the empty capsules market in France?

    France's empty capsules market is growing at a compound annual growth rate of 5.0% from 2025 to 2030.

    What factors are driving growth in France's empty capsules market?

    Growth in France is driven by robust pharmaceutical manufacturing, rising healthcare expenditure, personalized medicine demand, and increased consumer adoption of capsule-based nutraceuticals.

    Which capsule types are most prevalent in France's market?

    France's market includes both gelatin-based and plant-based empty capsules, with demand driven by pharmaceutical manufacturers and nutraceutical producers seeking quality delivery systems.

    RESEARCH METHODOLOGY

    This research extensively utilized secondary sources, directories, and databases to gather valuable information for analyzing the global empty capsules market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Empty capsules market. The secondary sources used for this study includes European Federation of Pharmaceutical Industries and Associations (EFPIA), United States Food and Drug Administration (US FDA), Central Drugs Standard Control Organisation (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), National Institutes of Health (NIH), World Health Organization (WHO), among others. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After an initial assessment of the global empty capsules market landscape through secondary research, comprehensive primary research was conducted. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from the pharmaceutical, nutraceutical, and cosmetic industries, as well as research laboratories. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from leading empty capsules manufacturers, distributors, and channel partners. The research covered six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. About 70% of the primary interviews were with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and phone discussions to thoroughly understand market dynamics.

    The following is a breakdown of the primary respondents:

    Empty Capsules Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both bottom-up and top-down approaches were used to estimate and validate the total size of the empty capsules market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    A list of the major global players operating in the empty capsules market was generated.

    The revenues generated from their empty capsules product have been determined through annual reports and secondary sources (including paid databases)

    The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.

    The combined revenue share of the players was estimated and then added up to 100% to derive the global empty capsules market.

    All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

    Global Empty Capsules Market Size: Bottom-up and Top-down Approach

    Empty Capsules Market

    Data Triangulation

    After determining the market size through the estimation process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used whenever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

    Market Definition

    A capsule is a form of solid oral dosage that consists of a container, usually made of gelatin or HPMC material, filled with a medicinal substance. Empty capsules are hard shells of various shapes, typically designed to hold a single dose of active ingredients. At the time of sale, these capsules are not filled with any pharmaceutical or nutraceutical ingredients. They are made in two halves: a smaller-diameter “body” that is filled and sealed with a larger-diameter “cap”.

    Stakeholders

    • Empty Capsules Manufacturing Companies
    • Pharmaceutical Companies
    • Nutraceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Manufacturing Organizations (CMOs)
    • Research Laboratories & Academic Institutes.
    • Market Research & Consulting Firms
    • Regulatory Bodies

    Report Objectives

    • To define, describe, and forecast the empty capsules market based on type, raw material, functionality, size, therapeutic application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the empty capsules market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global Empty capsules market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the empty capsules market
    • To benchmark players within the empty capsules market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business strategies and product footprints.

    Get the Full Empty Capsules Market Report

    Full forecast, segment splits, and company analysis for all Empty Capsules Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status